share

Tridehydro Pirlimycin CAS NO 78788-60-0


Unit Price:

CAS No.:78788-60-0

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Tridehydro Pirlimycin is a semi-synthetic lincosamide antibiotic derivative, primarily recognized for its potent antibacterial activity. This compound is of significant interest in pharmaceutical research and development for creating advanced antimicrobial agents. It serves as a critical intermediate for the synthesis of novel veterinary and human therapeutics targeting Gram-positive bacterial infections. Key industries requiring this high-purity intermediate include pharmaceutical manufacturing, veterinary medicine, and advanced chemical research.

Application

  • Pharmaceutical Intermediate: A key building block in the synthesis of next-generation lincosamide antibiotics for clinical use.
  • Veterinary Drug Development: Used in research and production of mastitis treatments and other antibacterial formulations for livestock.
  • Antimicrobial Research: Serves as a reference standard and active compound in studies investigating mechanisms of action against resistant bacterial strains.
  • Chemical Synthesis: Employed in organic synthesis for the modification and creation of new antibiotic analogs with improved efficacy.
  • Biochemical Studies: Utilized in laboratory settings to study protein synthesis inhibition and bacterial ribosome interactions.

Basic Information

Product Name Tridehydro Pirlimycin
CAS No. 78788-60-0
Molecular Formula C17H31ClN2O5S
Molecular Weight 410.96 g/mol
Synonyms U-57930E; (2S,4R)-N-[(1S,2S)-2-Chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide; Pirlimycin Impurity; Dehydro Pirlimycin; Antibiotic U-57930E; Lincosamide derivative
EINECS Contact for details

Quality Control

Our Tridehydro Pirlimycin is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. We provide comprehensive analytical documentation, including a Certificate of Analysis (COA) detailing identity, purity, and impurity profiles as determined by HPLC, IR, and other pharmacopeial methods. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates, ensuring reliability for your critical synthesis processes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). The product is hygroscopic (moisture-sensitive) and should be kept under inert conditions for long-term storage to maintain stability.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to reference spectrum
Identification (HPLC) Retention time corresponds to reference standard
Assay (HPLC) ≥ 98.0%
Related Substances (HPLC) Total impurities ≤ 2.0%
Single Maximum Impurity ≤ 0.5%
Water Content (KF) ≤ 1.0%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.